ArticlePLOS digital health2026
Diagnostic performance of the ECG-SMART AI score for detecting angiographically significant coronary artery disease in patients undergoing elective coronary angiography.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 12-lead ECG is central to the evaluation of patients with suspected coronary artery disease (CAD) but has limited diagnostic accuracy for identifying significant obstructive disease prior to elective coronary angiography. We previously developed an artificial intelligence-enhanced ECG (AI-ECG) model for detecting acute coronary occlusion. Whether this model generalizes to identifying angiographically significant CAD in symptomatic patients undergoing elective evaluation remains unknown. In this prospective cohort study, symptomatic outpatients undergoing elective coronary angiography at a tertiary center received standard 12-lead ECGs before the procedure. ECGs were analyzed offline using a previously validated AI-ECG model originally developed for acute coronary occlusion. Patients were categorized as low or intermediate-to-high risk using predefined thresholds. The primary outcome was angiographically significant CAD (≥70% stenosis in a major epicardial vessel or ≥50% stenosis of the left main coronary artery). Among 363 patients (age 58.9 ± 11 years; 55.1% male), 36.1% had angiographically significant CAD. The AI-ECG classified 56% as low risk and 44% as intermediate-to-high risk. After adjustment for conventional clinical characteristics, intermediate-to-high risk remained independently associated with significant CAD (OR 3.12, 95% CI 1.88-5.20; p < 0.001). Model discrimination was good (AUROC 0.79, 95% CI 0.74-0.84), with 60% precision at 80% recall. In summary, the ECG-SMART AI score demonstrated good diagnostic performance for identifying angiographically significant CAD in symptomatic patients undergoing elective coronary angiography. These findings support the generalizability of a previously developed AI-ECG model beyond acute coronary occlusion and suggest that AI-enhanced ECG analysis may complement existing clinical assessment by providing additional noninvasive information to refine pretest probability during elective evaluation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.